MDT

88.65

+1.69%↑

VEEV

282.96

-1.55%↓

A

120.24

+1.92%↑

HQY

102.79

-1.67%↓

PHR.US

28.46

+0.21%↑

MDT

88.65

+1.69%↑

VEEV

282.96

-1.55%↓

A

120.24

+1.92%↑

HQY

102.79

-1.67%↓

PHR.US

28.46

+0.21%↑

MDT

88.65

+1.69%↑

VEEV

282.96

-1.55%↓

A

120.24

+1.92%↑

HQY

102.79

-1.67%↓

PHR.US

28.46

+0.21%↑

MDT

88.65

+1.69%↑

VEEV

282.96

-1.55%↓

A

120.24

+1.92%↑

HQY

102.79

-1.67%↓

PHR.US

28.46

+0.21%↑

MDT

88.65

+1.69%↑

VEEV

282.96

-1.55%↓

A

120.24

+1.92%↑

HQY

102.79

-1.67%↓

PHR.US

28.46

+0.21%↑

Search

GoodRx Holdings Inc

Uždarymo kaina

SektoriusSveikatos priežiūra

4.97 -0.2

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

4.92

Max

5.05

Pagrindiniai rodikliai

By Trading Economics

Pajamos

4.3M

11M

Pardavimai

4.4M

203M

P/E

Sektoriaus vid.

67

50.291

Pelnas, tenkantis vienai akcijai

0.09

Pelno marža

5.445

Darbuotojai

738

EBITDA

-15M

27M

Rekomendacijos

By TipRanks

Rekomendacijos

Pirkti

12 mėnesių prognozė

+29.39% upside

Dividendai

By Dow Jones

Kitas uždarbis

2025-08-07

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

89M

1.7B

Ankstesnė atidarymo kaina

5.17

Ankstesnė uždarymo kaina

4.97

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Very Strong Bearish Evidence

GoodRx Holdings Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-07-01 23:09; UTC

Uždarbis

Constellation Brands 1Q Profit, Sales Decline Amid Softer Consumer Demand -- Update

2025-07-01 19:16; UTC

Įsigijimai, susijungimai, perėmimai

Sabadell Seeks Shareholder Approval of Nearly $4 Billion Sale of U.K. Unit to Santander

2025-07-01 23:47; UTC

Rinkos pokalbiai

Nikkei May Fall Amid U.S. Tariff Uncertainty -- Market Talk

2025-07-01 23:41; UTC

Rinkos pokalbiai

Gold Steady, Underpinned by U.S. Fiscal-Deficit Concerns -- Market Talk

2025-07-01 22:23; UTC

Įsigijimai, susijungimai, perėmimai

James Hardie: Deal Represents Implied Value of $8.4 Billion

2025-07-01 22:23; UTC

Įsigijimai, susijungimai, perėmimai

James Hardie: Cash and Stock Deal Implies $54.18 Per AZEK Share

2025-07-01 22:21; UTC

Įsigijimai, susijungimai, perėmimai

James Hardie Completes Acquisition of AZEK

2025-07-01 20:50; UTC

Rinkos pokalbiai

Health Care Roundup: Market Talk

2025-07-01 20:50; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2025-07-01 20:24; UTC

Uždarbis

Constellation Brands Earnings Miss as Consumers Cool on Alcohol -- Barrons.com

2025-07-01 19:55; UTC

Rinkos pokalbiai

Oil Futures Resume Cautious Rally -- Market Talk

2025-07-01 19:27; UTC

Rinkos pokalbiai

U.S. Natural Gas Futures Lose More Ground -- Market Talk

2025-07-01 19:12; UTC

Rinkos pokalbiai

Dollar Little Changed as Tax-And-Spending Bill Advances -- Market Talk

2025-07-01 19:01; UTC

Įsigijimai, susijungimai, perėmimai

Sabadell Seeks Shareholder Approval of Nearly $4B Sale of U.K. Unit to Santander

2025-07-01 18:41; UTC

Įsigijimai, susijungimai, perėmimai

How DexCom, Insulet, and Amedisys Might Be Affected by Medicare Cuts -- Barrons.com

2025-07-01 18:33; UTC

Rinkos pokalbiai

Market Talk Roundup: Latest on U.S. Politics

2025-07-01 18:33; UTC

Rinkos pokalbiai

Gold Gains as Investors Look Ahead on Budget Bill -- Market Talk

2025-07-01 18:32; UTC

Rinkos pokalbiai

Mexico Manufacturing PMIs Remain Weak in June -- Market Talk

2025-07-01 18:22; UTC

Rinkos pokalbiai

Remittances to Mexico Down in May -- Market Talk

2025-07-01 17:45; UTC

Rinkos pokalbiai

Seasonal Demand Supports Further Oil Gains -- Market Talk

2025-07-01 17:01; UTC

Įsigijimai, susijungimai, perėmimai

Danone Completed Acquisition of Majority Stake in Kate Farms

2025-07-01 16:55; UTC

Uždarbis

10 European Dividend Stocks That Could Beat Their U.S. Counterparts -- Barrons.com

2025-07-01 16:27; UTC

Rinkos pokalbiai

Trade Concerns Ease in Bank of Mexico Survey -- Market Talk

2025-07-01 16:25; UTC

Rinkos pokalbiai
Įsigijimai, susijungimai, perėmimai

Home Depot's GMS Buy Unlocks New Vertical Adjacent to SRS -- Market Talk

2025-07-01 16:20; UTC

Rinkos pokalbiai

Health Care Roundup: Market Talk

2025-07-01 15:48; UTC

Rinkos pokalbiai
Įsigijimai, susijungimai, perėmimai

Home Depot's Offer for GMS Unlikely to Be Beat -- Market Talk

2025-07-01 15:46; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2025-07-01 15:46; UTC

Rinkos pokalbiai

Amazon Seen With Improved Logistics Ahead of Longer Prime Day -- Market Talk

2025-07-01 14:54; UTC

Rinkos pokalbiai

Thales Expected to Stick to This Year's Sales Guidance -- Market Talk

2025-07-01 14:49; UTC

Rinkos pokalbiai

Platinum Prices Extend Rally on China Demand, Supply Worries -- Market Talk

Akcijų palyginimas

Kainos pokytis

GoodRx Holdings Inc Prognozė

Kainos tikslas

By TipRanks

29.39% į viršų

12 mėnesių prognozė

Vidutinis 6.34 USD  29.39%

Aukščiausias 9 USD

Žemiausias 4 USD

Remiantis 12 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines GoodRx Holdings Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

12 ratings

7

Pirkti

4

Laikyti

1

Parduoti

Techninis įvertinimas

By Trading Central

3.675 / 4.65Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Very Strong Bearish Evidence

Vidutinės trukmės periodas

Weak Bearish Evidence

Ilgalaikis periodas

Weak Bearish Evidence

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę GoodRx Holdings Inc

GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices. It also offers other healthcare products and services, including subscriptions, and pharma manufacturer solutions, as well as telehealth services through the GoodRx Care platform. It serves pharmacy benefit managers who manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. The company was founded in 2011 and is headquartered in Santa Monica, California.